April 12, 2024
(Reuters) – The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk’s hugely popular Wegovy, are […]
April 11, 2024
TOPLINE: Breaking up long sitting periods with short, frequent bouts of light-intensity walks may reduce the increased levels of postprandial vascular inflammatory biomarkers seen in people […]
April 11, 2024
TOPLINE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be a better adjunct treatment to reduce anemia risk than glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for patients […]
April 10, 2024
TOPLINE: Surgery and radioactive iodine (RAI) are associated with a lower risk for long-term major adverse cardiovascular events (MACE) than long-term use of antithyroid drugs in […]
April 9, 2024
TOPLINE: In people with type 2 diabetes (T2D), higher levels of arm and trunk fat are associated with an increased risk for cardiovascular disease (CVD) and […]
April 9, 2024
TOPLINE: Monthly cycles of a fasting-mimicking diet (FMD) may slow metabolic and immune system aging and reduce the risk for metabolic disease. METHODOLOGY: In two clinical […]
April 9, 2024
Statins raise the risks for increased glucose levels and the development of type 2 diabetes among people who don’t have it at baseline, but those risks […]
April 8, 2024
TOPLINE: Semaglutide results in more weight loss if patients with overweight or obesity have not previously been treated with anti-obesity medications. METHODOLOGY: Studies of semaglutide, a […]
April 8, 2024
TOPLINE: Adults with excess weight or obesity tend to experience higher levels of pain intensity than those with a normal weight, highlighting the importance of addressing […]